Literature DB >> 2850939

Persistence of poliovirus-neutralizing antibodies 2-16 years after immunization with live attenuated vaccine. A seroepidemiologic survey in the mainland of Venice.

R Trivello1, G Renzulli, G Farisano, C Bonello, M Moschen, V Gasparini, G Benussi.   

Abstract

A seroepidemiological survey was conducted on subjects who had received a full vaccination course with live attenuated poliovirus 2-16 years before. For strains 1 and 2 prevalence of seropositives and median values dropped gradually during the first 10 years; strain 3 showed a much earlier decline. Environmental displacement of wild poliovirus by the attenuated, less immunogenic strain might eventually induce a 'gap', should complacency hamper needed vaccination efforts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2850939      PMCID: PMC2249418          DOI: 10.1017/s0950268800029472

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  7 in total

1.  Persistence of poliovirus neutralizing antibodies eight years after immunization with live, attenuated-virus vaccine.

Authors:  W E Rousseau; G R Noble; G E Tegtmeier; M C Jordan; T D Chin
Journal:  N Engl J Med       Date:  1973-12-20       Impact factor: 91.245

2.  Surveillance of paralytic poliomyelitis in the United States. 1966 and 1967 cases, and 1965-1967 cases associated with oral poliovirus vaccine.

Authors:  C C Hopkins; W E Dismukes; T H Glick; R J Warren
Journal:  JAMA       Date:  1969-10-27       Impact factor: 56.272

3.  Inadequate poliovirus immunity levels in immunized Illinois children.

Authors:  C M Rasmussen; C W Thomas; R J Mulrooney; R A Morrissey
Journal:  Am J Dis Child       Date:  1973-10

4.  Developing gap in immunity to poliomyelitis in an urban area.

Authors:  J L Melnick; M Burkhardt; L H Taber; P N Erckman
Journal:  JAMA       Date:  1969-08-25       Impact factor: 56.272

5.  Poliomyelitis in the United States, 1969-1981.

Authors:  M Moore; P Katona; J E Kaplan; L B Schonberger; M H Hatch
Journal:  J Infect Dis       Date:  1982-10       Impact factor: 5.226

6.  Recommendations for a national policy on poliomyelitis vaccination.

Authors:  E O Nightingale
Journal:  N Engl J Med       Date:  1977-08-04       Impact factor: 91.245

7.  Seroimmunity to poliomyelitis in Sweden after the use of inactivated poliovirus vaccine for 10 years.

Authors:  M Böttiger; B Zetterberg; C R Salenstedt
Journal:  Bull World Health Organ       Date:  1972       Impact factor: 9.408

  7 in total
  6 in total

1.  Antipoliomyelitis neutralizing antibodies in maternal and neonatal serum.

Authors:  M L Tanzi; P Colotto; M Vignali; P Affanni; U Bracchi; E Bellelli
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

2.  Antipoliomyelitis immunity status among a population that was regularly vaccinated 11-12 years before.

Authors:  E Bellelli; M L Tanzi; V Bocelli; U Bracchi; P Affanni
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

3.  Seroprevalence of antipolio antibodies among children <15 years of age in border provinces in China.

Authors:  HaiBo Wang; Hui Cui; ZhenGrong Ding; Pian Ba; ShuangLi Zhu; Ning Wen; LiXin Hao; Jing Ning; Jie Zhang; De Yang; WenBo Xu; Yong Zhang; ChunXiang Fan; WenZhou Yu; XiaoFeng Liang; HuiMing Luo
Journal:  Clin Vaccine Immunol       Date:  2013-05-15

4.  Persistence of immunity to poliomyelitis among a southern population that received four doses of OPV 5 to over 15 years before.

Authors:  M Triassi; G Ribera; L Barruffo; S Barbone; E Medda; M E Grandolfo
Journal:  Eur J Epidemiol       Date:  1996-02       Impact factor: 8.082

Review 5.  Interrupting the transmission of wild polioviruses with vaccines: immunological considerations.

Authors:  Y Ghendon; S E Robertson
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

6.  Sero-survey of polio antibodies during wild poliovirus outbreak in southern Xinjiang Uygur Autonomous Region, China.

Authors:  Hai-Bo Wang; Shuang-Li Zhu; Jing-Shan Zheng; Ai-Li Gou; Hui Cui; Yong Zhang; Gui-Jun Ning; Chun-Xiang Fan; Yuan-Sheng Chen; Ke-Li Li; Ping Yuan; Chao Ma; Jing Ma; Hui Zheng; Xin-Chun Fan; Xin-Lan Li; Hai-Shu Tang; Xiao-Lei Li; Fan Zhang; Dong-Mei Yan; Dong-Yan Wang; Zhi-Qiang Cui; Li-Ping Ren; Hui Zhu; Hui-Ling Wang; Xiao-Hong Jiang; Hong-Qiu An; Yang Liu; Jing Li; Wen-Bo Xu; Ning Wen; Ai-Qiang Xu; Hui-Ming Luo
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.